ロード中...
Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients
BACKGROUND: Colistin is a last-line defense therapy against extensively drug-resistant Acinetobacter baumannii (XDR-AB). Despite a loading dose of colistin being applied in many clinical practices, studies evaluating the effect of the loading dose of colistin in cancer patients remain limited. PATIE...
保存先:
| 出版年: | Infect Drug Resist |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5593398/ https://ncbi.nlm.nih.gov/pubmed/28919792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S144314 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|